Molecular monitoring of viral infections in immunocompromised patients in a large university hospital in Italy: reflections after thirteen years of real-life activity

L Cinti, P Roberto, M Rossi, A Napoli, G Russo… - European Journal of …, 2024 - Springer
Purpose This study aimed to investigate the prevalence and viral reactivations of clinical
interest in the immunocompromised patient with particular focus on hematologic and solid …

Adjunct Acupuncture Improved Respiratory Status and Weaning from Mechanical Ventilation After Severe COVID-19 Pneumonia

J Matsumoto-Miyazaki, H Okada, T Miura… - Medical …, 2024 - liebertpub.com
Background: A patient with severe COVID-19 pneumonia had adjunctive acupuncture to
improve respiration and facilitate weaning off prolonged mechanical ventilation (MV). Case …

[PDF][PDF] Posicionamiento de la Sociedad Española de Medicina de Urgencias y Emergencias (SEMES) ante el tratamiento antiviral frente al SARS-CoV-2 en la …

JG del Castillo, A Julián-Jiménez - Emergencias, 2024 - revistaemergencias.org
Actualmente, la COVID-19 sigue representando una amenaza significativa, con una
mortalidad cercana al doble de la ocasionada por la gripe y con una incidencia variable …

ВЛИЯНИЕ СОПУТСТВУЮЩИХ ЗАБОЛЕВАНИЙ НА ТЯЖЕСТЬ ТЕЧЕНИЯ COVID-19

СГ Щербак, АМ Сарана, АЮ Анисенкова… - Университетский …, 2024 - ojs3.gpmu.org
Аннотация Уже в начале пандемии было замечено влияние сопутствующих
заболеваний на степень тяжести и исходы COVID-19. С тех пор большое внимание …

The influence of comorbid diseases on the profiles of signaling biomarkers (macrophage-derived chemokine, interferon-γ-induced protein 10 kD, soluble CD40 ligand …

AY Anisenkova, VI Mazurov… - HERALD of North …, 2023 - journals.eco-vector.com
BACKGROUND: Analysis of the effect of comorbid diseases on the concentration of
biomarkers will help to deepen the understanding of the pathogenetic mechanisms of the …

[PDF][PDF] A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Comirnaty COVID-19 mRNA vaccine to prevent …

S Pathera, N Charpentiera, F van den Ouwelanda… - brightoncollaboration.org
Working Group evaluates the safety and other key features of new platform technology
vaccines, including nucleic acid (RNA and DNA) vaccines. This manuscript uses the …